Bhagirathbhai R Dholaria

70PUBLICATIONS
320CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Sep 02, 2026
Teclistamab and Daratumumab Immune-Based Doublet Therapy for Relapsed/Refractory Multiple Myeloma: the TRIMM-2 Study.

|Aug 31, 2026
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

|Aug 19, 2026
Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial.

|Jul 20, 2026
Redefining functional high-risk multiple myeloma in the context of upfront quadruplet therapy and autologous stem cell transplantation.

|May 19, 2026
Consensus recommendations for CAR T-cell administration in adult acute lymphoblastic leukemia: a modified Delphi study.

|Feb 11, 2026
American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults.

Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung

Pageof 12

Frequent Collaborators

11 joint publications

Oluwole O Olalekan

10 joint publications

Bipin Savani

8 joint publications

Taiga Nishihori

7 joint publications

Reena V Jayani-Kosarzycki